Cagan Gurer

Company: TScan Therapeutics
Job title: VP, Discovery
Seminars:
Expanding Patient Coverage for TCR-T Therapies by Broadening HLA Type Targeting 9:30 am
• Application of TargetScan discovery platform to diverse HLA types for novel target epitope identification • Using ReceptorScan to identify lead TCRs for novel HLA epitopes • Leveraging proprietary human proteome libraries across diverse HLAs to assess potential off-target safety risks for TCRsRead more
day: Day Two